Masters Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Masters Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-300,000	Closed	-$17.5M	–	88
2025 Q4	$16.2M	Buy	300,000 +100,000	+50%	+$4.81M	0.66%	49
2025 Q3	$9.02M	Sell	200,000 -50,000	-20%	-$2.34M	0.33%	63
2025 Q2	$11.6M	Buy	+250,000	New	+$12.3M	0.45%	47
2021 Q4	–	Sell	-500,000	Closed	-$29.6M	–	66
2021 Q3	$29.6M	Buy	+500,000	New	+$32.9M	1.22%	26
2018 Q3	–	Sell	-286,280	Closed	-$17M	–	81
2018 Q2	$15.8M	Buy	+286,280	New	+$15.5M	0.45%	44
2017 Q4	–	Sell	-300,000	Closed	-$18.8M	–	63
2017 Q3	$19.1M	Buy	+300,000	New	+$17.5M	0.45%	48

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Masters Capital Management's BMY Position: Q1 2026 in Review

Masters Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 300,000 shares — an estimated $17.5M sold.

Masters Capital Management first reported a position in BMY in Q3 2017 and held it in 6 quarters. The position peaked at $29.6M in Q3 2021. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Masters Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
Masters Capital Management sold 300,000 Bristol-Myers Squibb shares in Q1 2026, an estimated $17.5M.
Masters Capital Management first reported a position in Bristol-Myers Squibb in Q3 2017 and held it in 6 quarters.
Masters Capital Management's Bristol-Myers Squibb position peaked at $29.6M in Q3 2021.
2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Masters Capital Management's 13F filing for Q1 2026, filed 15 May 2026.